A carregar...
Adjuvant GM-CSF Improves Survival in High Risk Stage IIIc Melanoma: A Single Center Study
OBJECTIVES: Stage III melanoma is associated with an increased risk of recurrence and death. Complete surgical resection remains the best chance for cure. Unfortunately, no adjuvant therapy has demonstrated a consistent improvement in melanoma-specific survival. We hypothesize that adjuvant GM-CSF m...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3664256/ https://ncbi.nlm.nih.gov/pubmed/23428946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e31827def82 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|